Brief: Cannara Biotech Inc. Reports Fiscal Third Quarter 2022 Financial Results
Cannara Biotech Inc LOVE.V :
* CANNARA BIOTECH INC. REPORTS FISCAL THIRD QUARTER 2022
FINANCIAL
RESULTS
* CANNARA BIOTECH INC - QUARTERLY REVENUE OF $10.1 MILLION,
A 36%
INCREASE FROM PREVIOUS QUARTER AND A 41% INCREASE COMPARED TO Q3
2021
* CANNARA BIOTECH INC - QTRLY RECORDED GROSS PROFIT BEFORE
FAIR
VALUE ADJUSTMENTS OF $3.7 MILLION, A 42% INCREASE FROM PREVIOUS
QUARTER
Source text for Eikon: ID:nPn2Flz5Ga
Further company coverage: LOVE.V
Recent news on Cannara Biotech
See all newsCanada Research Roundup: Cannara Biotech ,Equinox Gold , Winpak
Brief: Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced At C$2.10 Per Common Share
Brief: Cannara Biotech Delivers Q4
Cannabis firm Cannara Biotech's Q4 revenue rises on market expansion
Brief: Cannara Biotech Q4 EPS CAD 0.04